Abstract
Photodynamic Therapy (PDT) is an evolving cancer treatment that depends on three known and variable components: photosensitizer, light and oxygen. Optimization of these variables yields reactive oxygen species, mainly singlet oxygen, that damage cellular components leading to cytotoxicity. Our research has demonstrated that porphyrin sensitizers, in particular, significantly inhibit the inner mitochondrial membrane enzymes cytochrome c oxidase and F 0 F 1 ATP synthase. These results were obtained from an in vivo-in vitro experimental protocol that exposes sensitizers to metabolic and pharmacokinetic events. The resulting inhibition of oxidative phosphorylation was expected to reduce ATP levels, which were quantitated in cells and were confirmed by 31P-NMR spectroscopy of tumors in situ in animals treated with PDT.
Based on these findings, and more recent investigations of apoptosis, there is little doubt that mitochondria are critical targets in the actions of PDT.
Similar content being viewed by others
References
Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL (1991) Cancer Res 51:5993–5996
Berns MW, Dahlman A, Johnson FM, Burns R, Sperling D, Guiltinan M, Siemens A, Walter R, Wright W, Hammer-Wilson M, Wile A (1982) Cancer Res 42:2325–2329
Ceckler TL, Bryant RG, Penney DP, Gibson SL, Hilf R (1986) Biochem Biophys Res Commun 140:273–279
Ceckler TL, Gibson SL, Kennedy SD, Hilf R, Bryant RG (1991) Br J Cancer 63:916–922
Chopp M, Farmer H, Hetzel F, Schaap AP (1987) Photochem Photobiol 46:819–822
Das M, Dixit R, Mukhtar H, Bickers DR (1985) Cancer Res 45:608–615
Dixit R, Mukhtar H, Bickers DR (1983) Photochem Photobiol 37:173–176
Fiel RJ, Datta-Gupta N, Mark EH, Howard JC (1981) Cancer Res 41:3543–3545
Gibson SL, Hilf R (1983) Cancer Res 43:4191–4197
Gibson SL, Murant RS, Chazen MD, Kelly ME, Hilf R (1989) Br J Cancer 59:47–53
Gomer CJ (1980) Cancer Lett 11:161–167
Gutter B, Speck WT, Rosenkranz HS (1977) Biochim Biophys Acta 475:307–314
Hilf R, Michel I, Bell C, Freeman JJ, Borman A (1965) Cancer Res 25:286–299
Hilf R (1967) Science 155:826–827
Hilf R, Smail DB, Murant RS, Leakey PB, Gibson SL (1984) Cancer Res 44:1483–1488
Hilf R, Murant RS, Narayanan U, Gibson SL (1986) Cancer Res 46:211–217
Hilf R, Gibson SL, Penney DP, Ceckler TL, Bryant RG (1987) Photochem Photobiol 46:809–817
Kessel D (1977) Biochemistry 16:3443–3449
Kohn K, Kessel D (1979) Biochem Pharmacol 28:2465–2470
Moan J, Waksvik H, Christensen T (1980) Cancer Res 40:2915–2918
Moan J, Berg K (1991) Photochem Photobiol 53:549–553
Murant RS, Gibson SL, Hilf R (1987) Cancer Res 47:4323–4328
Oleinick NL, Morris RL, Belichenko I (2002) Photochem Photobiol Sci 1:1–21
Perlin DS, Murant RS, Gibson SL, Hilf R (1985) Cancer Res 45:653–658
Senior AE, McGowan SE, Hilf R (1975) Cancer Res 35:2061–2067
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hilf, R. Mitochondria are targets of photodynamic therapy. J Bioenerg Biomembr 39, 85–89 (2007). https://doi.org/10.1007/s10863-006-9064-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-006-9064-8